What to watch. Biocon gets USFDA booster for Vizag unit

Shares of Biocon may see buying activity, as the company on Monday informed the exchanges of a clean chit it received from the USFDA. In a notification to the exchanges, the biotechnology company said its active pharmaceutical ingredients facility at Visakhapatnam, Andhra Pradesh, has completed the USFDA audit from September 11 to 15 without any observations. Biocon had acquired the unit from Acacia Lifesciences in October 2015.